Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP); Initial Review, 19989 [2015-08519]
Download as PDF
<![CDATA[
Federal Register / Vol. 80, No. 71 / Tuesday, April 14, 2015 / Notices
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–08521 Filed 4–13–15; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES (HHS)
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
Prevention and the Agency for Toxic
Substances and Disease Registry.
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC) announce
the following meeting for the
aforementioned committee:
Time and Date: 2:00 p.m.–3:00 p.m.,
EST, May 11, 2015.
Place: This meeting will be accessible
by teleconference. Toll-free +1 (888)
790–1864, Participant Code: 5920580.
Status: Open to the public limited
only by the availability of telephone
ports.
Purpose: The Committee is charged
with providing advice and guidance to
the Director, Division of Healthcare
Quality Promotion, the Director,
National Center for Emerging and
Zoonotic Infectious Diseases (NCEZID),
the Director, CDC, the Secretary, Health
and Human Services regarding (1) the
practice of healthcare infection
prevention and control; (2) strategies for
surveillance, prevention, and control of
infections, antimicrobial resistance, and
related events in settings where
healthcare is provided; and (3) periodic
updating of CDC guidelines and other
policy statements regarding prevention
of healthcare-associated infections and
healthcare-related conditions.
Matters for Discussion: The agenda
will include a follow up discussion on
the Draft Guideline for the Prevention of
Surgical Site Infections. Call materials
will be made available to the public no
later than 2 business days before the
call. If CDC is unable to post the
background material on the HICPAC site
prior to the meeting, the background
material will be posted on HICPAC’s
Web site after the meeting. Background
material is available at https://
www.cdc.gov/hicpac.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Erin Stone, M.S., HICPAC, Division of
Healthcare Quality Promotion, NCEZID,
CDC, 1600 Clifton Road NE., Mailstop
A–31, Atlanta, Georgia 30333; Email:
HICPAC@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
[FR Doc. 2015–08518 Filed 4–13–15; 8:45 am]
BILLING CODE 4163–18–P
Board of Scientific Counselors, Office
of Infectious Diseases, BSC, OID
asabaliauskas on DSK5VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC),
announces the following meeting of the
aforementioned committee:
Time and Date: 8:00 a.m.–5:00 p.m.,
EDT, May 6, 2015.
Place: CDC, Global Communications
Center, 1600 Clifton Road NE., Building
19, Auditorium B3, Atlanta, Georgia
30333.
Status: The meeting is open to the
public, limited only by the space
available.
Purpose: The BSC, OID, provides
advice and guidance to the Secretary,
Department of Health and Human
Services; the Director, CDC; the
Director, OID; and the Directors of the
National Center for Immunization and
Respiratory Diseases, the National
Center for Emerging and Zoonotic
Infectious Diseases, and the National
Center for HIV/AIDS, Viral Hepatitis,
STD, and TB Prevention, CDC, in the
following areas: Strategies, goals, and
priorities for programs; research within
the national centers; and overall
strategic direction and focus of OID and
the national centers.
Matters for Discussion: The meeting
will include a report from the Food
Safety Modernization Act Surveillance
Working Group of the BSC, OID; brief
updates on priority issues for CDC’s
infectious disease programs; and
updates and discussions on CDC’s
Surveillance Strategy and the Global
Health Security Agenda.
Agenda items are subject to change as
priorities dictate.
Contact Person for More Information:
Robin Moseley, M.A.T., Designated
Federal Officer, OID, CDC, 1600 Clifton
Road NE., Mailstop D10, Atlanta,
Georgia 30333, Telephone: (404) 639–
4461.
The Director, Management Analysis
and Services Office has been delegated
Centers for Disease Control and
Prevention
VerDate Sep<11>2014
17:42 Apr 13, 2015
Jkt 235001
19989
Disease, Disability, and Injury
Prevention and Control Special
Emphasis Panel (SEP); Initial Review
The meeting announced below
concerns Comparison and Validation of
Screening Tools for Substance Use
Among Pregnant Women, DP15–003,
initial review.
SUMMARY: This document corrects a
notice that was published in the Federal
Register on March 12, 2015 Volume 80,
Number 48, page 13011. The times and
dates should read as follows:
Times and Dates: 9:00 a.m.–6:00 p.m.,
April 7–8, 2015 (Closed).
M.
Chris Langub, Ph.D., Scientific Review
Officer, CDC, 4770 Buford Highway NE.,
Mailstop F46, Atlanta, Georgia 30341,
Telephone: (770)488–3585, EEO6@
cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
FOR FURTHER INFORMATION CONTACT:
Claudette Grant,
Acting Director, Management Analysis and
Services Office, Centers for Disease Control
and Prevention.
[FR Doc. 2015–08519 Filed 4–13–15; 8:45 am]
BILLING CODE 4163–18–P
PO 00000
Frm 00035
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention
Healthcare Infection Control Practices
Advisory Committee (HICPAC)
E:\FR\FM\14APN1.SGM
14APN1
]]>Agencies
[Federal Register Volume 80, Number 71 (Tuesday, April 14, 2015)]
[Notices]
[Page 19989]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-08519]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Disease, Disability, and Injury Prevention and Control Special
Emphasis Panel (SEP); Initial Review
The meeting announced below concerns Comparison and Validation of
Screening Tools for Substance Use Among Pregnant Women, DP15-003,
initial review.
SUMMARY: This document corrects a notice that was published in the
Federal Register on March 12, 2015 Volume 80, Number 48, page 13011.
The times and dates should read as follows:
Times and Dates: 9:00 a.m.-6:00 p.m., April 7-8, 2015 (Closed).
FOR FURTHER INFORMATION CONTACT: M. Chris Langub, Ph.D., Scientific
Review Officer, CDC, 4770 Buford Highway NE., Mailstop F46, Atlanta,
Georgia 30341, Telephone: (770)488-3585, EEO6@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Claudette Grant,
Acting Director, Management Analysis and Services Office, Centers for
Disease Control and Prevention.
[FR Doc. 2015-08519 Filed 4-13-15; 8:45 am]
BILLING CODE 4163-18-P
